Changes in Endothelial-Related Goagulation Proteins in Response to Venous Occlusion

Summary

One hundred patients with a history of thrombophilia wer divided into two groups based on fibrinolytic response to venous occlusion. Good responders with a euglobulin clot lysis time ≤ 105 min showed significant release of tPA, PAI and vWE Of the poor responders with an ECIX > 105 min, 24% showed a subnormal increase in tPA, and a significant proportion of these also showed a reduced or absent rise in vWE

We have shown poor fibrinolytic response was related to either raised levels of PAI, poor release of both tPA and vWR or poor release of tPA or vWF alone suggesting different mechanisms of fibrinolytic impairment. Protein S levels were not significantly changed in either group following occlusion.

• References

• 1 Lijnen HR, Collen D. Congenital and acquired deficiencies of the components of the fibrinolytic system and their relation to bleeding or thrombosis. Fibrinolysis 1989; 3: 67-77
• 2 Isacson S, Nilsson IM. Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis. Acta Chir Scand 1972; 138: 313-319
• 3 Booth NA, Bennett B, Wijngaard G, Grieve JHK. A new life-long hemorrhagic disorder due to excess plasminogen activator. Blood 1983; 6l: 267-275
• 4 Juhan-Vague I, Valadier J, Alessi MC, Aillaud MR, Ansaldi J, Philip-Joet C, Holvoet R, Serradimigni A, Collen D. Deficient tPA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemostas 1981; 57: 67-72
• 5 Alessi MC, Juhan-Vague I, Valadier J, Philip-Joet C, Holvoet R, Collen D. Relevance of free tPA assay following venous occlusion in patients with venous thromboembolic disease. Thromb Haemostas 1988; 59: 346-347
• 6 Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH. The frequency of type L heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemostas 1988; 59: 18-22
• 7 Rodgers GM. Haemostatic properties of normal and perturbed vascular cells. EASEB J 1988; 2: 1l6-123
• 8 Chesterman CN. Vascular endothelium, haemostasis and thrombosis. Blood Rev 1988; 2: 88-94
• 9 Fair DS, Marlar RA, Levin EG. Endothelial cells synthesise protein S. Blood 1986; 67: 1168-1171
• 10 Goodall AH, Jarvis J, Chand S, Rawlings E, O’Brien D, McGraw A, Hutton R, Tuddenham EGD. An immunoradiometric assay for human factor VIIUvon Willebrand factor (VIII : vWF) using a monoclonal antibody that defines a functional epitope. Br J Haematol 1985; 59: 565-578
• 11 Jennings I, Luddington RI. An enzyme-linked immunosorbent assay for measurement of protein S. Med Lab Sci 1989; 46: 50-53
• 12 Petaja J, Rasi V, Myllyla G, Vahtera E, Hallman H. Familial hypofibrinolysis and venous thrombosis. Br J Haematol 1989; 71: 393-398
• 13 Nicoloso G, Hauert J, Kruithoff EKO, Van Melle G, Bachmann E. Fibrinolysis in normal subjects - comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Thromb Haemostas 1988; 59: 299-303
• 14 Kruithoff EKO, Nicoloso G, Bachmann E. Plasminogen activator inhibitor L: Development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood 1987; 70: 1645-1653
• 15 Tianquille N, Emeis JJ. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region. Thromb Haemostas 1990; 63: 454-458
• 16 Jones DK, Luddington R, Higenbottam Tw, Scott J, Cavarocchi N, Reardon D, Calvin J, Wallwork J. Changes in factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage. Thromb Haemostas 1988; 60: 199-204